Article info
Ovarian Cancer
LAPTM4B Overexpression is a Novel Independent Prognostic Marker for Metastatic Ovarian Tumors
- Address correspondence and reprint requests to Ge Lou, MD, PhD, Department of Gynecology, The Affiliated Tumor Hospital, Harbin Medical University, 150081, Harbin, China. E-mail: louge{at}ems.hrbmu.edu.cn.
Citation
LAPTM4B Overexpression is a Novel Independent Prognostic Marker for Metastatic Ovarian Tumors
Publication history
- Received April 30, 2011
- Accepted August 29, 2011
- First published January 1, 2012.
Online issue publication
January 01, 2012
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2012 by IGCS and ESGO